Company Search:
Advanced Search
Sponsored Links
Neuron Bio SA Company Snapshot
Neuron Bio SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neuron Bio SA with three other miscellaneous service companies in Europe: Ose Immunotherapeutics SA of France (2016 sales of 383,000.00 Euro [US$451,652.75 ] ), Shield Therapeutics PLC of the United Kingdom (£304,000.00 [US$401,584.00 ] of which 100% was Feraccru), and Physiomics PLC which is also based in the United Kingdom (£297,120.00 [US$392,495.52 ] of which 100% was Outsourced Systems and Computational Bio).

Sales Analysis. During the year ended December of 2016, sales at Neuron Bio SA were 436,573.00 Euro (US$514.83 thousand). This is an increase of 116.7% versus 2015, when the company's sales were 201,451.00 Euro. This was the third consecutive year of growth at Neuron Bio SA. The sales level in 2016 was fairly close to the level five years ago: in 2011, Neuron Bio SA had sales of 418,316.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neuron Bio SA
  Stock Performance Chart for Neuron Bio SA
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2017): .30
(Figures in Euro)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Neuron Bio SA Key Data:
  Ticker: NEU Country: Spain
  Exchanges: MAD Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 436,573
(Year Ending Jan 2017).
Employees: 26
  Currency: Euro Market Cap: 3,783,069
  Fiscal Yr Ends: December Shares Outstanding: 12,610,229
  Share Type: Accion Closely Held Shares: 1,021,596
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.